Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs COPX✓SelectedUSD · COPXGSK vs COPX performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs COPX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
COPX return
+289.9%
Excess return
-186.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCOPXExcessAlpha
1D-2.3%-0.3%-2.0%-2.3%
7D-3.0%-10.4%+7.4%-1.3%
30D+0.4%-18.3%+18.7%+3.5%
3M-1.2%-25.2%+24.0%+3.1%
6M+0.9%-21.1%+22.0%+3.7%
YTD+4.0%-8.7%+12.7%+2.9%
1Y+7.3%+11.9%-4.6%+2.1%
3Y+57.1%+103.6%-46.5%+29.8%
5Y+43.0%+104.2%-61.3%+15.2%
10Y+103.1%+296.7%-193.7%+27.1%
All+103.1%+289.9%-186.8%+27.1%

Cumulative growth

Daily Returns

Daily percentage return beside COPX.

Daily Out/Under-Performance

Portfolio return minus COPX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × COPX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded COPX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling